Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

1.8.1.7: glutathione-disulfide reductase

This is an abbreviated version!
For detailed information about glutathione-disulfide reductase, go to the full flat file.

Word Map on EC 1.8.1.7

Reaction

2 glutathione +

NADP+
=
glutathione disulfide
+
NADPH
+
H+

Synonyms

At3g54660, EC 1.6.4.2, GLR, glutahione reductase, glutathione disulfide reductase, glutathione reductase, glutathione reductase (NADPH), glutathione reductase 3, glutathione reductase Glr1, glutathione S-reductase, glutathione: NADP(+) oxidoreductase, glutathione: NADP+ oxidoreductase, glutathione:NADP+ oxidoreductase, Gor, GOR1, GOR2, GR, GR1, GR2, Gr3, GRase, GRase-1, GRd, GSH reductase, GSHR, Gsr, GSR-1, GSSG reductase, HCOI_01258400, hGR, HvGR1, HvGR2, multifunctional thioredoxin-glutathione reductase, NADPH-glutathione reductase, NADPH-GSSG reductase, NADPH-reduced GR, NADPH: oxidized glutathione oxidoreductase, NADPH:oxidized glutathione oxidoreductase, NADPH:oxidized-glutathione oxidoreductase, OBP29, PfGR, psgr, PtGR1.1, PtGR1.2, PtGR2, reductase, glutathione, SpGR, TaGR1, TaGR2, TGR, thioredoxin glutathione reductase, thioredoxin/glutathione reductase, TrxR3

ECTree

     1 Oxidoreductases
         1.8 Acting on a sulfur group of donors
             1.8.1 With NAD+ or NADP+ as acceptor
                1.8.1.7 glutathione-disulfide reductase

Inhibitors

Inhibitors on EC 1.8.1.7 - glutathione-disulfide reductase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(1R(S),2R(S),3S(R),4S(R))-2,3-dihydroxycyclo-hexane-1,4-diyl dinitrate
-
non-competitive inhibition
(1R(S),2R(S),4R(S),5R(S))-2,5-dihydroxycyclo-hexane-1,4-diyl dinitrate
-
non-competitive inhibition
(1S(R),2S(R),5R(S),6R(S))-5-bromo-9-oxabicyclo[4.2.1] nonan-2-yl nitrate
-
non-competitive inhibition
(1S(R),3S(R),4S(R),6S(R))-4,6-dihydroxycyclo-hexane-1,3-diyl dinitrate
-
non-competitive inhibition
(2R(S),7R(S))-7-hydroxybicyclo[2.2.1]heptan-2-yl nitrate
-
non-competitive inhibition
(2S(R),7R(S))-7-hydroxybicyclo[2.2.1] heptan-2-yl nitrate
-
non-competitive inhibition
(9R(S))-hydroxy-1,2,3,4-tetrahydro-1,4-methano-naphthalen-2R(S)-yl nitrate
-
non-competitive inhibition
1,2-bis[methylsulfonyl]-1-[2-[chloroethyl]-2-(methylamino)carbonyl]hydrazine
-
0.05 mM, 28% inhibition
1,2-Cyclohexanedione
-
-
1,3-Bis(2-chloroethyl)-1-nitrosourea
-
significant inhibition of recombinant isoform GR1 is observed at high concentrations of 1 mM and above
1,3-bis-(2-chloroethyl) 1-nitrosourea
1,3-Bis-(2-chloroethyl)-1-nitrosourea
1,3-bis[2-chloroethyl]-2-nitrosourea
1,4-dihydroxy-9,10-anthraquinone
1,4-Naphthoquinone
1,8-dihydroxy-9,10-anthraquinone
1,9-dimethyl methylene blue
-
-
1-(2-Chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea
-
-
1-chloro-2,4-dinitrobenzene
-
reversible
1-Fluoro-2,4-dinitrobenzene
-
reversible
1-methyl-4-(2-methyl-1,3-dioxo-2,3,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-5(1H)-yl)pyridinium
poor inhibitor
11-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)undecanoic acid
2,3-Butanedione
-
-
2,3-dimethylquinoxaline-5,8-dione
2,4,6-Trinitrobenzenesulfonate
2,4-dihydroxybenzylamine
-
specific inhibitor, complete inhibition at 0.001 mM
2,5-bis(aziridin-1-yl)-3,6-bis[(2-hydroxyethyl)amino]cyclohexa-2,5-diene-1,4-dione
-
-
2,5-bis(aziridin-1-yl)-3,6-dimethylcyclohexa-2,5-diene-1,4-dione
-
-
2,5-bis(aziridin-1-yl)-3-(hydroxymethyl)-6-methylcyclohexa-2,5-diene-1,4-dione
2,5-bis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione
-
-
2,5-bis(ethylamino)-3,6-di(aziridinyl)-1,4-benzoquinone
2,6-dimethyl-1,4-benzoquinone
2-acetylamino-3-[4-(2-acetylamino-2-carboxy-ethylsulfanylthio carbonylamino)phenylthiocarbamoylsulfanyl]propionic acid
-
irreversible and selective glutathione reductase inhibitor, almost complete inhibition at 0.1 mM for 1 h, thereafter, the enzyme activity starts to return and reaches 63% of the control at the end of 8 h
2-acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid
-
irreversible glutathione reductase inhibitor
2-Chloroethylisocyanate
-
-
2-Hydroxy-1,4-naphthoquinone
2-hydroxy-3-methyl-1,4-naphthoquinone
2-methyl-1,4-naphthoquinone
2-methyl-5-(1-naphthyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
2-methyl-5-pyridin-4-yl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
3'-hydroxy-4'-O-methylisoscutellarein 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
-
-
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-aminium
-
3-[5-[8-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)octyl]-1H-tetrazol-1-yl]propanenitrile
4,5-dichloro-N-octylisothiazol-3-one
-
-
5,8-Dihydroxy-1,4-naphthoquinone
5-(1-anthryl)-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
5-(3alpha,12alpha-dihydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha-hydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(4-chlorophenyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
5-(4-chlorophenyl)-8-fluoro-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
5-(pentafluorophenyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
5-chloro-N-methylisothiazol-3-one
-
-
5-hydroxy-1,4-naphthoquinone
5-nitro-2-furoic acid
-
-
5-nitroindole
-
-
6,7-dimethylquinoline-5,8-dione
6-methylquinoline-5,8-dione
6-[2-(3-fluoromethyl)-1,4-naphthoquinolyl]hexanoic acid
6-[2-(3-methyl)-1,4-naphthoquinolyl]hexanoic acid
7-methylquinoline-5,8-dione
8-azido-5-(4-chlorophenyl)-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
9,10-phenanthrene quinone
acetaminophen-glutathione conjugate
acylfulvene
-
reversible inhibition, less than 10% residual activity at 1.25 mM, inhibition by 1.0 or 1.25 mM acylfulvene is reduced by 30% in the presence of NDPH
AgNO3
ajoene
-
i.e. (E,Z)-4,5,9-trithiadodeca-1,6,11-triene-9-oxide, natural compound from garlic, Allium sativum, covalent inhibition, but also substrate; time- and temperature-dependent inhibition, mixed disulfide between cative site Cys58 and the inhibitor, modified enzyme shows a markedly increased oxidative activity
allyl isothiocyanate
-
apigenin
-
flavonone, non-competitive with both NADPH and GSSG, influence on glutathione recognition
arsenite
auranofin
-
complete inhibition of both enzyme reductase activities at 10 nM
BaCl2
Baicalin
-
slightly, flavone glycoside, non-competitive with both NADPH and GSSG, influence on glutathione recognition
Benzyl isothiocyanate
-
Benzylselenosulfate
-
-
bis[1,3,5-triazino[1,2-a]benzimidazole-2-amine,3,4-dihydro-4-(2-imidazole)]copper(II) bromide
-
bis[1,3,5-triazino[1,2-a]benzimidazole-2-amine,3,4-dihydro-4-(2-thiophene)]copper(II) bromide
-
CaCl2
-
0.25 mM, 9.1% loss of activity
captopril
-
20 mM, 46.6% decrease of activity
carmustine
catechin
-
slightly, catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
CdCl2
-
0.25 mM, 80.9% loss of activity
cefodizime
cefotaxime
ceftazidime
-
competitive inhibition
ceftriaxone
-
competitive inhibition
cefuroxime
-
competitive inhibition
chloramphenicol
-
competitive inhibition
chloro[N(4)-ortho-chlorophenyl-2-acetylpyridinethiosemicarbazonato]gold(III)dichloroaurate(I)
-
in addition, the complex is highly cytotoxic to MCF-7 and HT29 cells
chromate
chrysin
-
slightly, flavonone, non-competitive with both NADPH and GSSG, influence on glutathione recognition
cisplatin
-
0.01-0.2 mM
CoCl2
-
0.25 mM, 72.7% loss of activity
Cr3+
-
competitive inhibition
CrCl2
-
0.25 mM, 52.7% loss of activity
Cu+
-
presence of Cu+ inhibits noncompetitively with respect to the substrate GSSG and NADPH and inactivates with the cleavage of a peptide bond of the enzyme. Inactivation/fragmentation is prevented by addition of catalase
CuCl2
-
0.25 mM, 79.7% loss of activity
dantrolene
-
non-competitive inhibition
diclofenac sodium
-
competitive inhibition
diethyl dicarbonate
-
chloroplast enzyme, 100% inhibition at 4 mM, 23% inhibition at 1 mM
diethyl [2,5-bis(aziridin-1-yl)-3,6-dioxocyclohexa-1,4-diene-1,4-diyl]biscarbamate
-
-
diethyldicarbonate
-
-
digoxin
-
noncompetitive
dinitrosated isomers of N,N'-bis[N(2-chloroethyl)-N-carbonyl]cysteamine
-
-
-
dopamine
-
competitive
EDTA
-
0.25 mM, 71.8% loss of activity
epicatechin
-
slightly, catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
epicatechin gallate
-
slightly, catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
epigallocatechin
-
slightly, catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
epigallocatechin gallate
-
catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
ethyl [5-(3,5-dichlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetate
ethyl [5-(3-chlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetate
-
etomidate
-
competitive inhibition
FeCl2
-
0.25 mM, 55.5% loss of activity
fisetin
-
flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
Furosemide
-
noncompetitive
gadopentetic acid
-
non-competitive inhibition
gallic acid
-
slightly
glutathione
GSH
-
With regard to GSSG as variable substrate at fixed NADPH concentration (0.1 mM), GSH is a non-competitive inhibitor. With regard to NADPH as variable substrate at fixed GSSG concentration, GSH is a non-competitive inhibitor
H2O2
-
inactivates with the cleavage of a peptide bond of the enzyme. Inactivation/fragmentation is prevented by addition of catalase
Haemin
-
mediates covalent cross-linking and degradation of the enzyme
HgCl2
-
0.25 mM, 89.1% loss of activity
hydroxymethylacylfulvene
-
irreversible inhibition, less than 10% residual activity at 1.25 mM, inhibition by 0.625 or 1.25 mM hydroxymethylacylfulvene is reduced by 45% in the presence of NDPH
hypericin
when is glutathione disulfide is the variable substrate, hypericin inhibits the enzyme competitively
hypolaetin 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
-
-
Imipenem
-
competitive inhibition
iodoacetamide
iodoacetate
isoscutellarein 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
-
-
K+
-
inhibitory in 0.1-1.0 M concentration range
kaempferol
-
slightly, flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
Ketoprofen
-
competitive inhibition
ketotifen
-
non-competitive inhibition
L-gamma-glutamyl-2-methyl-L-cysteinyl-glycine disulfide
-
competitive inhibitor
lornoxicam
-
competitive inhibition
Melarsen oxide
Melatonin
meloxicam
-
non-competitive inhibition
menadione
mercuric sulfate
-
-
methylene blue
impairs the activity of recombinant form of the enzyme
monohydrated complex of cisplatin
-
0.01-0.2 mM
morin
-
slightly, flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
morphine
-
competitive inhibition
myricetin
-
flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea
-
-
N,N,2-trimethyl-3-(10H-phenothiazin-10-yl)propan-1-amine
-
N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
-
N,N-dimethyl-3-(10H-phenothiazin-10-yl)propan-1-aminium
-
N,N-dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propan-1-aminium
-
N-(2-cyanoethyl)-9-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)nonanamide
N-Acetylimidazole
-
-
N-Alkylmaleimide
-
-
N-ethylmaleimide
Na2S2O3
-
-
Na2SO4
-
IC50: 0.45 M
NaBr
-
above 0.2 M
NADH-X
-
-
NADPH-X
-
-
new methylene blue
-
-
NH4+
-
inhibitory in 0.1-1.0 M concentration range
NH4Cl
-
IC50: 0.62 M
Nicotine
-
0.5 mg/kg, significant inhibition of enzymatic activity in liver (61.5%), lung (65%), heart (70.5%), stomach (72.5%), kidney (64%) and testicle (71.5%)
nifurtimox
Nitrofurantoin
nitrofurazone
-
-
Nitrogen mustard
-
-
ornidazole
-
competitive inhibition
oxaliplatin
-
0.01-0.2 mM
p-chloromercuribenzoate
p-chloromercuriphenyl sulfonate
-
-
p-hydroxymercuribenzoate
Pb(NO3)2
-
0.25 mM, complete loss of activity
peroxynitrite
phenethyl isothiocyanate
-
phenyl mercuric acetate
Phenylarsonous acid
-
-
Phenylglyoxal
Phenylmethylsulfonylfluoride
-
i.e. PMSF, chloroplast enzyme, slight inhibition
phenyramidol
-
competitive inhibition
phosphate buffer
-
-
-
propofol
-
noncompetitive inhibition
putrescine
-
the early decrease of glutathione reductase activity in leaves treated with polyamines can be due to a direct interaction of these compounds with the enzyme
pyridoxal 5'-phosphate
-
70% inactivation, due to specific modification of an epsilon-amino group lysine residue
quercetin
-
flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
quinoxaline-5,8-dione
riboflavin
-
-
rifamycin
-
competitive inhibition
rutin
-
slightly, flavonol glycoside, non-competitive with both NADPH and GSSG, influence on glutathione recognition
S-(2,4-dinitrophenyl)-glutathione
-
-
Sn2+
-
non-competitive inhibition
Sodium acetate
-
IC50: 0.77 M
spermidine
-
the early decrease of glutathione reductase activity in leaves treated with polyamines can be due to a direct interaction of these compounds with the enzyme
spermine
-
the early decrease of glutathione reductase activity in leaves treated with polyamines can be due to a direct interaction of these compounds with the enzyme
sulfanylacetamide
-
competitive inhibition
sulfhydryl reagents
-
in presence but not in absence of reduced coenzyme
sulforaphane
-
tenoxicam
-
competitive inhibition
tetrakis(2-amino-1,3,5-triazine)copper(II) bromide
-
tetramethyl-1,4-benzoquinone
TH-302
-
TH-302 at 300 mg/kg significantly inhibits glutathione reductase activity by 60% as compared with the controls, at 3 h after the injection
toluidine blue O
-
-
trans-(1S(R),2S(R))-2-hydroxycyclohexyl nitrate
-
non-competitive inhibition
trans-(1S(R),2S(R))-2-hydroxycyclooctyl nitrate
-
non-competitive inhibition
trans-(1S(R),6S(R))-6-hydroxycyclohex-3-enyl nitrate
-
non-competitive inhibition
trans-(1S(R),8S(R),Z)-8-hydroxycyclooct-4-enyl nitrate
-
non-competitive inhibition
trans-(R(S))-2-hydroxy-1-phenylethyl nitrate
-
non-competitive inhibition
trimethyl-1,4-benzoquinone
trimethyl-aziridinyl-1,4-benzoquinone
Urea
-
activation: 0.4-0.6 M, inactivation at higher concentration
Vancomycin
-
noncompetitive inhibition
ZnCl2
-
0.25 mM, 66.4% loss of activity
[4-(3-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalen-2-yl)phenyl]acetic acid
[4-[3-(fluoromethyl)-1,4-dioxo-1,2,3,4-tetrahydronaphthalen-2-yl]phenyl]acetic acid
[5-(3,5-dichlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetic acid
[{1-phenyl-2,5-di(2-pyridyl)phosphole}AuCl]
-
gold-phosphole inhibitor, 1 nM, 50% inhibition, reversible
additional information
-